Works matching IS 03065251 AND DT 1989 AND VI 27 AND IP S1

Results: 20

Neuropathology of vigabatrin.

Published in:

British Journal of Clinical Pharmacology, 1989, v. 27, n. S1, p. 43S, doi. 10.1111/j.1365-2125.1989.tb03460.x

By:

Graham, D

Publication type:

Article

Vigabatrin in epilepsy in mentally retarded patients.

Published in:

British Journal of Clinical Pharmacology, 1989, v. 27, n. S1, p. 113S, doi. 10.1111/j.1365-2125.1989.tb03471.x

By:

Matilainen, R;
Pitkanen, A;
Ruutiainen, T;
Mervaala, E;
Riekkinen, P

Publication type:

Article

Clinical pharmacology of vigabatrin.

Published in:

British Journal of Clinical Pharmacology, 1989, v. 27, n. S1, p. 19S, doi. 10.1111/j.1365-2125.1989.tb03456.x

By:

Schechter, PJ

Publication type:

Article

Response to vigabatrin in relation to seizure type.

Published in:

British Journal of Clinical Pharmacology, 1989, v. 27, n. S1, p. 119S, doi. 10.1111/j.1365-2125.1989.tb03472.x

By:

Michelucci, R;
Tassinari, CA

Publication type:

Article

Effects of long term vigabatrin on somatosensory evoked potentials in epileptic patients.

Published in:

British Journal of Clinical Pharmacology, 1989, v. 27, n. S1, p. 69S, doi. 10.1111/j.1365-2125.1989.tb03464.x

By:

Liegeois-Chauvel, C;
Marquis, P;
Gisselbrecht, D;
Pantieri, R;
Beaumont, D;
Chauvel, P

Publication type:

Article

Vigabatrin in the treatment of epilepsy in children.

Published in:

British Journal of Clinical Pharmacology, 1989, v. 27, n. S1, p. 109S, doi. 10.1111/j.1365-2125.1989.tb03470.x

By:

Livingston, JH;
Beaumont, D;
Arzimanoglou, A;
Aicardi, J

Publication type:

Article

Effects of vigabatrin on evoked potentials in epileptic patients.

Published in:

British Journal of Clinical Pharmacology, 1989, v. 27, n. S1, p. 61S, doi. 10.1111/j.1365-2125.1989.tb03463.x

By:

Cosi, V;
Callieco, R;
Galimberti, CA;
Manni, R;
Tartara, A;
Mumford, J;
Perucca, E

Publication type:

Article

Cerebrospinal fluid GABA and seizure control with vigabatrin.

Published in:

British Journal of Clinical Pharmacology, 1989, v. 27, n. S1, p. 87S, doi. 10.1111/j.1365-2125.1989.tb03467.x

By:

Riekkinen, PJ;
Ylinen, A;
Halonen, T;
Sivenius, J;
Pitkanen, A

Publication type:

Article

Effect of food on the absorption of vigabatrin.

Published in:

British Journal of Clinical Pharmacology, 1989, v. 27, n. S1, p. 23S, doi. 10.1111/j.1365-2125.1989.tb03457.x

By:

Frisk-Holmberg, M;
Kerth, P;
Meyer, P

Publication type:

Article

A multicentre study of vigabatrin for drug-resistant epilepsy.

Published in:

British Journal of Clinical Pharmacology, 1989, v. 27, n. S1, p. 95S, doi. 10.1111/j.1365-2125.1989.tb03468.x

By:

Browne, TR;
Mattson, RH;
Penry, JK;
Smith, DB;
Treiman, DM;
Wilder, BJ;
Ben- Menachem, E;
Miketta, RM;
Sherry, KM;
Szabo, GK

Publication type:

Article

Effects of vigabatrin on evoked potentials in dogs.

Published in:

British Journal of Clinical Pharmacology, 1989, v. 27, n. S1, p. 53S, doi. 10.1111/j.1365-2125.1989.tb03462.x

By:

Arezzo, JC;
Schroeder, CE;
Litwak, MS;
Steward, DL

Publication type:

Article

Experimental studies of the influence of vigabatrin on the GABA system.

Published in:

British Journal of Clinical Pharmacology, 1989, v. 27, n. S1, p. 13S, doi. 10.1111/j.1365-2125.1989.tb03455.x

By:

Gram, L;
Larsson, OM;
Johnsen, A;
Schousboe, A

Publication type:

Article

The effect of different vigabatrin treatment regimens on CSF biochemistry and seizure control in epileptic patients.

Published in:

British Journal of Clinical Pharmacology, 1989, v. 27, n. S1, p. 79S, doi. 10.1111/j.1365-2125.1989.tb03466.x

By:

Ben-Menachem, E;
Persson, LI;
Schechter, PJ;
Haegele, KD;
Huebert, N;
Hardenberg, J;
Dahlgren, L;
Mumford, JP

Publication type:

Article

The effect of vigabatrin on brain and platelet GABA-transaminase activities.

Published in:

British Journal of Clinical Pharmacology, 1989, v. 27, n. S1, p. 35S, doi. 10.1111/j.1365-2125.1989.tb03459.x

By:

Bolton, JB;
Rimmer, E;
Williams, J;
Richens, A

Publication type:

Article

Effects of vigabatrin and of GABA on myelinated rat cerebellar cultures: preliminary data.

Published in:

British Journal of Clinical Pharmacology, 1989, v. 27, n. S1, p. 47S, doi. 10.1111/j.1365-2125.1989.tb03461.x

By:

Hauw, JJ;
Boutry, JM;
Sun, P;
Sazdovitch, V;
Duyckaerts, C

Publication type:

Article

Efficacy and safety of vigabatrin in the long-term treatment of refractory epilepsy.

Published in:

British Journal of Clinical Pharmacology, 1989, v. 27, n. S1, p. 125S, doi. 10.1111/j.1365-2125.1989.tb03473.x

By:

Remy, C;
Beaumont, D

Publication type:

Article

GABAergic mechanisms in the pathogenesis and treatment of epilepsy.

Published in:

British Journal of Clinical Pharmacology, 1989, v. 27, n. S1, p. 3S, doi. 10.1111/j.1365-2125.1989.tb03454.x

By:

Meldrum, BS

Publication type:

Article

Changes in CSF and brain soluble proteins following vigabatrin treatment in rats.

Published in:

British Journal of Clinical Pharmacology, 1989, v. 27, n. S1, p. 73S, doi. 10.1111/j.1365-2125.1989.tb03465.x

By:

Persson, LI;
Ronnback, L;
Ben-Menachem, E;
Eriksson, P;
Nilsson, M

Publication type:

Article

Interaction between vigabatrin and phenytoin.

Published in:

British Journal of Clinical Pharmacology, 1989, v. 27, n. S1, p. 27S, doi. 10.1111/j.1365-2125.1989.tb03458.x

By:

Rimmer, EM;
Richens, A

Publication type:

Article

Meta-analysis of European placebo controlled studies of vigabatrin in drug resistant epilepsy.

Published in:

British Journal of Clinical Pharmacology, 1989, v. 27, n. S1, p. 101S, doi. 10.1111/j.1365-2125.1989.tb03469.x

By:

Mumford, JP;
Dam, M

Publication type:

Article